People around the country are now having their lives saved by a medicine made from the blood of people in Manchester ...

A patient from Telford who needed a lifesaving treatment developed from blood plasma has thanked donors. Over the past three ...

NHS patients around the country are receiving a lifesaving medicine made from the plasma of blood donors in Shropshire.

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

Fourth quarter 2024 total revenue of approximately $57.6 million, which includes TAVALISSE® net product sales of $31.0 million, REZLIDHIA® net product sales of $7.4 ...

Sophie Meredith, who developed thrombotic thrombocytopenic purpura (TTP), said without a ... which strengthen or stabilise the immune system. "I remember getting a leaflet and it said without ...

By contrast, adverse events after vaccination are usually mild and self-limiting; 1 per 3000–4000 vaccinated children develop febrile seizures, 1 in 40 000 develop immune thrombocytopenic purpura, and ...

Equities researchers at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Kamada in a note issued ...

Kamada (NASDAQ:KMDA – Get Free Report) is expected to announce its earnings results before the market opens on Wednesday, March 5th. Analysts expect the company to announce earnings of $0.05 per share ...